Fertility medicine

An embryo ( ) is the initial stage of development for a multicellular organism. In organisms that reproduce sexually, embryonic development is the part of the life cycle that begins just after fertilization of the female egg cell by the male sperm cell. The resulting fusion of these two cells produces a single-celled zygote that undergoes many cell divisions that produce cells known as blastomeres. The blastomeres are arranged as a solid ball that when reaching a certain size, called a morula, takes in fluid to create a cavity called a blastocoel. The structure is then termed a blastula, or a

In biology, infertility is the inability of a male and female organism to reproduce. It is usually not the natural state of a healthy organism that has reached sexual maturity, so children who have not undergone puberty, which is the body's start of reproductive capacity, are excluded. It is also a normal state in women after menopause.

assisted reproductive technology procedure (ART)

pregnancy through in vivo fertilization

methods used to achieve pregnancy by artificial or partially artificial means

facility that collects and stores human semen from sperm donors for use by women who need donor-provided sperm to achieve a pregnancy or pregnancies.

analysis that evaluates certain characteristics of a male's semen

diminished or absent ability of a female to achieve conception

in vitro fertilization procedure

method of assisted reproduction

form of asexual reproduction

Anovulation is when the ovaries do not release an oocyte during a menstrual cycle. Therefore, ovulation does not take place. However, a woman who does not ovulate at each menstrual cycle is not necessarily going through menopause. Chronic anovulation is a common cause of infertility.

medicine dealing with prevention, diagnosis and management of reproductive problems

human disease

Cetrorelix (, ), or cetrorelix acetate (, ), sold under the brand name Cetrotide, is an injectable gonadotropin-releasing hormone (GnRH) antagonist. A synthetic decapeptide, it is used in assisted reproduction to inhibit premature luteinizing hormone surges The drug works by blocking the action of GnRH upon the pituitary, thus rapidly suppressing the production and action of luteinizing hormone (LH) and follicle-stimulating hormone (FSH). In addition, cetrorelix can be used to treat hormone-sensitive cancers of the prostate and breast (in pre-/perimenopausal women) and some benign gynaecologic

inability to father a child

human embryo which has been genetically modified

human disease

2018 film by Tamara Jenkins

Ganirelix acetate (or diacetate), sold under the brand names Orgalutran and Antagon among others, is an injectable competitive gonadotropin-releasing hormone antagonist (GnRH antagonist). It is primarily used in assisted reproduction to control ovulation. The drug works by blocking the action of gonadotropin-releasing hormone (GnRH) upon the pituitary, thus rapidly suppressing the production and action of LH and FSH. Ganirelix is used in fertility treatment to prevent premature ovulation that could result in the harvesting of eggs that are too immature to be used in procedures such as in vitro

conservation biology

application of medical ultrasonography to the female pelvic organs

drug class affecting sex hormones

American custody case

test used for the evaluation of infertility

medications which enhance reproductive fertility

to give up an embryo without compensation

sperms and eggs are introduced in the fallopian tube for natural fertilization.

measure of male fertility

process for assessing human fertility

Surgical procedure

the stimulation of ovulation by medication

consultant gynaecologist, obstetrician and researcher

means of choosing what type of sperm cell (X-chromosome or Y-chromosome) is to fertilize the egg cell

technique used in vitro fertilization

assisted reproductive technique

surgical subspecialty of obstetrics and gynecology

for artificial insemination, or medical study (usually in fertility clinics)

procedure performed prior to in vitro fertilization

providing future reproductive opportunities before a medical treatment with known risk of loss of fertility

separation of individual sperm from semen

study of infertility in men

procedure in which spermatozoa are extracted from a legally dead person

Theoretical biological reproduction by LGBT people

right|thumb|Placing ovarian tissue strips into the preserving solution Oncofertility is a subfield that bridges oncology and reproductive research to support fertility preservation in cancer survivors. Cancer treatments, such as chemotherapy, radiation, and surgery, may reduce or destroy a person's ability to have children later in life. Oncofertility also encompasses reproductive issues after cancer treatment, such as family planning, complex contraception, hormonal management throughout survivorship, surrogacy, and adoption. , oncofertility services are available in most countries outside of

fraud in fertility medicine